Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas-Reference-Cited by-同舟云学术

Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomas

Published:2016-08-08 Issue:9 Volume:126 Page:3383-3388
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Calebiro Davide,Grassi Elisa S.,Eszlinger Markus,Ronchi Cristina L.,Godbole Amod,Bathon Kerstin,Guizzardi Fabiana,de Filippis Tiziana,Krohn Knut,Jaeschke Holger,Schwarzmayr Thomas,Bircan Rifat,Gozu Hulya Iliksu,Sancak Seda,Niedziela Marek,Strom Tim M.,Fassnacht Martin,Persani Luca,Paschke Ralf

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference20 articles.

1. Somatic Mutations in Thyroid Nodular Disease

2. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas

3. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas;Persani;J Clin Endocrinol Metab,2000

4. DGGE is more sensitive for the detection of somatic point mutations than direct sequencing;Trülzsch;BioTechniques,1999

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting EED as a key PRC2 complex mediator toward novel epigenetic therapeutics;Drug Discovery Today;2024-06

2. Biallelic loss‐of‐function variants of EZH1 cause a novel developmental disorder with central precocious puberty;American Journal of Medical Genetics Part A;2024-05-30

3. Heterozygous gain of function variant in GUCY1A2 may cause autonomous ovarian hyperfunction;European Journal of Endocrinology;2024-03-30

4. Hyperthyroidism;The Lancet;2024-02

5. Molecular testing in thyroid cancer;Diagnostic Molecular Pathology;2024